IP Library Granted Patent US 10,815,290
Granted Patent B2
US 10,815,290 · App. 15/775,298 · Granted Oct 27, 2020

NKG2D decoys

Inventors: Mesfin Gewe (Seattle, WA); Roland K. Strong (Seattle, WA); Martin Prlic (Seattle, WA); Peter Rupert (Seattle, WA); Thomas Spies (Seattle, WA); Veronika Spies (Seattle, WA)
Assignee: FRED HUTCHINSON CANCER RESEARCH CENTER
C07K14/7056A61K39/39A61P35/00C07K14/47C07K14/4705C07K16/2833C07K16/2851A61K38/00A61K2039/505A61K2039/55516C07K2317/76C07K2319/00C07K2319/43C07K2319/50C07K2319/70C07K2319/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,815,290
App. No.
15/775,298
Granted
Oct 27, 2020
Kind
B2
Abstract

Single chain, multimerized, and/or glycosylated NKG2D decoys are described. The NKG2D decoys have high affinity and avidity for surface bound and soluble NKG2D ligands and can be used to (i) identify NKG2D ligands; (ii) treat cancer, graft vs. host disease (GVHD), and inflammatory conditions; and (iii) potentiate an immune response against a vaccine as well as many other potential uses.

Claims (19)

1. A single chain protein comprising the formula x-y-z, wherein x comprises a multimerization domain, y comprises a first linker derived from NKG2D, and z comprises an extracellular fragment of NKG2D comprising the formula a-b-a, wherein:

a comprises SEQ ID NO. 79, and

b comprises SEQ ID NO. 81 or SEQ ID NO. 82.

2. A single chain protein of claim 1 , wherein x comprises SEQ ID NO. 80.

3. A single chain protein of claim 1 , wherein y comprises SEQ ID NO. 81 or SEQ ID NO. 82.

4. A single chain protein of claim 1 , wherein x comprises SEQ ID NO. 80 and y comprises SEQ ID NO. 81 or SEQ ID NO. 82.

5. A single chain protein of claim 1 , wherein y comprises SEQ ID NO. 81 and b comprises SEQ ID NO. 82.

6. A single chain protein of claim 1 , wherein x consists of the multimerization domain, y consists of the first linker derived from NKG2D, and z consists of a-b-a.

7. A single chain protein of claim 1 , wherein the multimerization domain is a C4b multimerization domain.

8. A single chain protein of claim 1 , wherein the multimerization domain is selected from SEQ ID NO. 7-39 and SEQ ID NO. 80.

9. A single chain protein of claim 1 , wherein the multimerization domain is directly linked to the first linker derived from NKG2D.

10. A single chain protein of claim 1 , wherein y excludes a Gly-Ser linker.

11. A single chain protein of claim 1 , wherein the first linker is derived from human NKG2D.

12. A single chain protein of claim 1 , wherein y-z comprises SEQ ID NO. 3.

13. A single chain protein of claim 1 , wherein the two copies of SEQ ID NO: 79 form an NKG2D homodimer comprising the extracellular binding fragment of NKG2D.

14. A single chain protein of claim 1 , wherein z excludes intracellular portions of human or murine NKG2D.

15. A single chain protein of claim 1 , comprising SEQ ID NO. 78.

16. A single chain protein of claim 1 , multimerized into a heptamer.

17. A single chain protein of claim 1 , formulated as a pharmaceutical composition.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Jun 22, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060434/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2018
From: STRONG, ROLAND K; PRLIC, MARTIN; GEWE, MESFIN; ROEPKE, SARAH; SPIES, THOMAS; SPIES, VERONIKA; RUPERT, PETER
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 047793/0876 →
Continuity (2)
Provisional Application 62253590 · Nov 10, 2015
Related Publication 20180371051A1 · Dec 27, 2018